These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9248813)

  • 1. Updated patient information for treatment of benign prostatic hyperplasia: a permanent challenge.
    Hartung R
    Eur Urol; 1997; 32 Suppl 2():42-4. PubMed ID: 9248813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.
    DiSantostefano RL; Biddle AK; Lavelle JP
    BJU Int; 2006 May; 97(5):1007-16. PubMed ID: 16542339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporating patient preferences into orthopaedic practice: should the orthopaedic encounter change?
    Bryant D; Bednarski E; Gafni A
    Injury; 2006 Apr; 37(4):328-34. PubMed ID: 16480987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Shared decision making: an approach to strengthening patient participation in rehabilitation].
    Faller H
    Rehabilitation (Stuttg); 2003 Jun; 42(3):129-35. PubMed ID: 12813649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quality of life assessment of the male with benign prostate hypertrophy].
    Nekić VC; Tiljak H; Petricek G; Soldo D; Nekić G; Buljan N
    Acta Med Croatica; 2007 Feb; 61(1):49-55. PubMed ID: 17593641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of benign prostatic hyperplasia treatments: how can we improve the outcome measures and success criteria?
    Mensink H
    Eur Urol; 1997; 32 Suppl 2():38-41. PubMed ID: 9248812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing patients with benign prostatic hyperplasia.
    Hicks RJ; Cook JB
    Am Fam Physician; 1995 Jul; 52(1):135-42, 145-6. PubMed ID: 7541601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Agency for Health Care Policy and Research. Clinical guidelines for the diagnosis and treatment of benign prostatic hyperplasia.
    Roehrborn CG
    Urol Clin North Am; 1995 May; 22(2):445-53. PubMed ID: 7539190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Benign prostatic hyperplasia: patients' perception of medical treatment and their expectations. Results of a french survey involving patients treated with finasteride].
    Teillac P
    Therapie; 2002; 57(5):473-83. PubMed ID: 12611202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of information on preference heterogeneity and individualized care.
    Basu A; Meltzer D
    Med Decis Making; 2007; 27(2):112-27. PubMed ID: 17409362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment options for benign prostatic hyperplasia.
    Portis AJ; Mador DR
    Can Fam Physician; 1997 Aug; 43():1395-404. PubMed ID: 9266125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
    Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
    BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries.
    Fourcade RO; Théret N; Taïeb C;
    BJU Int; 2008 May; 101(9):1111-8. PubMed ID: 18279447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Information and participation in decision-making about treatment: a qualitative study of the perceptions and preferences of patients with rheumatoid arthritis.
    Schildmann J; Grunke M; Kalden JR; Vollmann J
    J Med Ethics; 2008 Nov; 34(11):775-9. PubMed ID: 18974408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [How to plan the treatment of prostatic adenoma today?].
    Chatelain C; Conort P; Chartier-Kastler E; Boyer C; Bianchini JM; Richard F
    Bull Acad Natl Med; 1999; 183(3):615-34; discussion 634-7. PubMed ID: 10437290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving therapeutic outcomes in BPH through diagnosis, treatment and patient compliance.
    DeCastro J; Stone B
    Am J Med; 2008 Aug; 121(8 Suppl 2):S27-33. PubMed ID: 18675614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment options for benign prostatic hyperplasia in older men.
    Miano R; De Nunzio C; Asimakopoulos AD; Germani S; Tubaro A
    Med Sci Monit; 2008 Jul; 14(7):RA94-102. PubMed ID: 18591930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign prostatic hyperplasia. A review of diagnostic and treatment options.
    Pfeiffer GM; Giacomarra M
    Adv Nurse Pract; 1999 Apr; 7(4):31-6; quiz 37-8. PubMed ID: 10382383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.